Top compounds associated with response to OR4K13


Feature Type Standardized
Nominal ANOVA
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.041 0.2
mRNA GSK2636771 CTRPv2 pan-cancer AAC -0.05 0.2
mRNA MI-2 CTRPv2 pan-cancer AAC -0.061 0.2
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.042 0.2
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.04 0.2
mRNA pifithrin-mu CTRPv2 pan-cancer AAC -0.04 0.2
mRNA KU-60019 CTRPv2 pan-cancer AAC -0.04 0.2
mRNA Cyclopamine GDSC1000 pan-cancer AAC 0.061 0.2
mRNA OSU-03012 GDSC1000 pan-cancer AAC -0.04 0.2
mRNA Vinblastine GDSC1000 pan-cancer AAC -0.04 0.2
Download CSV